EGCG: Clinical Trials

7 trials of EGCG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Unknown 2
Phase 22Unknown 2

Follow EGCG: new trials by email Literature Review of EGCG trials Research Report on EGCG

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients
EGCG - Interstitial Pneumonia, Neoplasms Malignant
Phase 1 / Phase 2UnknownShandong Cancer Hospital and Institute782023-01-052023-05-30
Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer
EGCG - Esophageal Obstruction
Phase 1CompletedShandong Cancer Hospital and Institute182021-08-202024-04-03
Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis
EGCG - Epigallocatechin Gallate, Radio Dermatitis
Phase 1 / Phase 2UnknownShandong Cancer Hospital and Institute152011-09-012020-04-28
Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
Polyphenon E, Placebo - HIV Infection
Phase 1CompletedBaylor College of Medicine232010-12-012023-05-19
Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck
Erlotinib, Green Tea Polyphenon E - Cancer of Head and Neck, Neoplasms, Head and Neck
Phase 1CompletedEmory University252010-03-012018-12-05
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
silymarin, green tea extract (EGCG) - Chronic Hepatitis C, Oxidative Stress
Phase 1CompletedUniversity of North Carolina, Chapel Hill282009-11-012017-04-18
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Polyphenon E - Multiple Sclerosis
Phase 1CompletedLouisiana State University Health Sciences Center in New Orleans102009-02-012013-06-27

Conditions studied

Airway Obstruction (1)  ·  HIV Infections (1)  ·  Head and Neck Neoplasms (1)  ·  Hepatitis C, Chronic (1)  ·  Lung Diseases, Interstitial (1)  ·  Multiple Sclerosis (1)  ·  Neoplasms (1)

Sponsors

Shandong Cancer Hospital and Institute (3)  ·  Baylor College of Medicine (1)  ·  Emory University (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (4)  ·  China (2)

Top investigators

Dong M. Shin, MD (1)  ·  Filiz Seeborg, MD, MPH (1)  ·  Jesus F Lovera, MD, MSPH (1)  ·  Jinming Yu, M.D. (1)  ·  Ligang Xing, MD, PhD (1)  ·  Michael W Fried, MD (1)  ·  Roberto Arduino, MD (1)  ·  Roy L Hawke, PhD, PharmD (1)

Results publications

PMID 24444526, PMID 26298797, PMID 38632501

NIH funding

K23AT004433 (1), P50CA128613 (1), R21AT003892 (1), R21AT004673 (1)